Mechanisms and Frontiers of Treatment for Diabetes-Related Epilepsy. Journal of Biosciences and Medicines, 14, 57-73. doi: 10.4236/jbm.2026.143006 . Diabetes mellitus (DM) is a metabolic disease ...

Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the production of toxic amyloid beta peptides in the first place.

Alembic Pharmaceuticals has received approval from the United States Food and Drug Administration for its generic drug, ...

Lamotrigine is primarily used to treat seizures. According to IQVIA data, the estimated market size for the product is $27 ...

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Lamotrigine Orally Disintegrating Tablets USP, 25 mg, ...

Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), a Once-Daily, Two-Drug Regimen at CROI 2026 ...

Though increasingly prescribed in the U.S., a 2025 study linked gabapentin prescriptions for chronic low back pain with ...

Recently published Drug-Resistant Epilepsy Market Insights report includes a comprehensive understanding of current treatment ...

DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness ...

Indoco Remedies Ltd shares surged after receiving USFDA approval for Brivaracetam Oral Solution. | One of India's leading ...

The global epilepsy drugs market is poised for robust growth, estimated to increase from US$ 8.29 billion in 2025 to US$ ...